• Health & Medicine

Discovery could guide immunotherapy for lung cancer

Scientists have discovered a new type of immune cell that could predict which lung cancer patients will benefit most from immunotherapy treatment. Scientists have discovered a new type of immune cell that could predict which lung cancer patients will benefit most from immunotherapy treatment.

19 June 2017

• For Researchers

New funding for early detection research

The chances of survival increase significantly if cancer is detected at an early stage. We've announced new funding to drive progress in this promising area. The chances of survival increase significantly if cancer is detected at an early stage. We've announced new funding to drive progress in this promising area.

19 June 2017

• For Researchers

Celebrating our Engagement Prize winners

Our Engagement Prizes are awarded to those who show extraordinary commitment in actively engaging and involving the public and patients with science. Our Engagement Prizes are awarded to those who show extraordinary commitment in actively engaging and involving the public and patients with science.

19 June 2017

• Health & Medicine

Blood test could help personalise treatment for advanced prostate cancer

Scientists have developed a blood test that could help doctors select the best treatment for men with aggressive prostate cancer. Scientists have developed a blood test that could help doctors select the best treatment for men with aggressive prostate cancer.

19 June 2017

• For Researchers

Our Research Strategy: looking forward

In this look forward, Professors Peter Johnson and Karen Vousden outline how we will ensure that the CRUK community remains at the forefront of cancer research. In this look forward, Professors Peter Johnson and Karen Vousden outline how we will ensure that the CRUK community remains at the forefront of cancer research.

19 June 2017

• Health & Medicine
• Science & Technology

News digest - smoking rates falling, aspirin risks, breast cancer drug U-turn and… ‘tanning drugs’?

Smoking rates are falling, aspirin has risks as well as benefits and… what's behind the talk of ‘tanning drugs’? Here's our weekly news report. Smoking rates are falling, aspirin has risks as well as benefits and… what's behind the talk of ‘tanning drugs’? Here's our weekly news report.

17 June 2017

• Health & Medicine

Breast cancer drug approved for NHS England

The drug trastuzumab emtansine (Kadcyla) will soon be routinely available for patients in England with an advanced type of breast cancer. The drug trastuzumab emtansine (Kadcyla) will soon be routinely available for patients in England with an advanced type of breast cancer.

16 June 2017

• For Researchers

Grand Challenge: The beginning of a global movement against cancer

Grand Challenge was launched to catalyse a revolution in cancer research – 18 months later, we have awarded more than £70 million to four exceptional teams. Grand Challenge was launched to catalyse a revolution in cancer research – 18 months later, we have awarded more than £70 million to four exceptional teams.

14 June 2017

• For Researchers

The microbiome and cancer: what’s all the fuss about?

Researchers are increasingly interested in the link between cancer and the microbiome. We take a look at what's happening in this rapidly developing field. Researchers are increasingly interested in the link between cancer and the microbiome. We take a look at what's happening in this rapidly developing field.

13 June 2017

• Science & Technology
• Health & Medicine

News digest – Improving prostate cancer survival, a life-extending app, yoga and... a tribute to Professor Patrick Johnston.

Improving prostate cancer survival, a life-extending app, yoga and our tribute to the remarkable Professor Patrick Johnston. Here’s our weekly news report. Improving prostate cancer survival, a life-extending app, yoga and our tribute to the remarkable Professor Patrick Johnston. Here’s our weekly news report.

10 June 2017

• Science & Technology

Certain genetic faults could help predict success of immunotherapy

A certain group of genetic faults could be used to help predict if immunotherapy will work in cancer patients, according to a new US study. A certain group of genetic faults could be used to help predict if immunotherapy will work in cancer patients, according to a new US study.

9 June 2017

• For Researchers

Exploring a new direction in immunotherapy

Dr Edd James, an established immunologist, is taking his first steps into drug discovery with funding from our Small Molecule Project Award. Dr Edd James, an established immunologist, is taking his first steps into drug discovery with funding from our Small Molecule Project Award.

8 June 2017